Search Results

There are 6014 results for: content related to: Tardive dyskinesia and other movement disorders secondary to aripiprazole

  1. You have free access to this content
    Aripiprazole versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel-Kluge, Hany G El-Sayeh, Stefan Leucht and Jun Xia

    Published Online : 2 JAN 2014, DOI: 10.1002/14651858.CD006569.pub5

  2. You have free access to this content
    Aripiprazole alone or in combination for acute mania

    Intervention Review

    The Cochrane Library

    Rachel Brown, Matthew J Taylor and John Geddes

    Published Online : 17 DEC 2013, DOI: 10.1002/14651858.CD005000.pub2

  3. You have free access to this content
    Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology

    CNS Drug Reviews

    Volume 10, Issue 4, December 2004, Pages: 317–336, Marilyn A Davies, Douglas J. Sheffler and Bryan L. Roth

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00030.x

  4. Aripiprazole in Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Alessandra Nivoli, Eduard Vieta, Pages: 245–269, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch12

  5. Aripiprazole versus typical antipsychotic drugs for schizophrenia

    Intervention Review

    The Cochrane Library

    Jayanti Bhattacharjee and Hany G El-Sayeh

    Published Online : 16 JUL 2008, DOI: 10.1002/14651858.CD006617.pub3

  6. Aripiprazole for schizophrenia

    Intervention Review

    The Cochrane Library

    Hany George El-Sayeh and Carla Morganti

    Published Online : 19 APR 2006, DOI: 10.1002/14651858.CD004578.pub3

  7. Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co-administered with aripiprazole

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 565–570, D. W. Boulton, G. D. Kollia, S. Mallikaarjun and D. M. Kornhauser

    Version of Record online : 3 SEP 2012, DOI: 10.1111/j.1365-2710.2012.01331.x

  8. Aripiprazole, a Novel Atypical Antipsychotic Drug

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 2, February 2004, Pages: 212–228, Tami R. Argo, Ryan M. Carnahan and Dr. Paul J. Perry

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.2.212.33145

  9. Use of aripiprazole for delirium in the elderly: a short review

    Psychogeriatrics

    Volume 15, Issue 1, March 2015, Pages: 75–84, Eiji Kirino

    Version of Record online : 17 DEC 2014, DOI: 10.1111/psyg.12088

  10. Aripiprazole for autism spectrum disorders (ASD)

    Intervention Review

    The Cochrane Library

    Lauren E Hirsch and Tamara Pringsheim

    Published Online : 26 JUN 2016, DOI: 10.1002/14651858.CD009043.pub3

  11. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)

    Bipolar Disorders

    Volume 14, Issue 1, February 2012, Pages: 41–53, Berit X Carlson, Terence A Ketter, Wei Sun, Karen Timko, Robert D McQuade, Raymond Sanchez, Estelle Vester-Blokland and Ronald Marcus

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1399-5618.2011.00974.x

  12. Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 2, February 2004, Pages: 179–187, Dr. Suresh Mallikaarjun, Dr. Daniel E. Salazar and Dr. Steven L. Bramer

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003261901

  13. Aripiprazole versus placebo for schizophrenia

    Intervention Review

    The Cochrane Library

    Ravindra B Belgamwar and Hany George G El-Sayeh

    Published Online : 10 AUG 2011, DOI: 10.1002/14651858.CD006622.pub2

  14. Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: Possible relevance to neuroprotective interventions in schizophrenia

    Synapse

    Volume 62, Issue 11, November 2008, Pages: 804–818, Tsung-Tsair Yang and Su-Jane Wang

    Version of Record online : 20 AUG 2008, DOI: 10.1002/syn.20548

  15. Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 89–93, Dr Leslie Citrome, Dr Richard Josiassen, Dr Nigel Bark, Dr Daniel E. Salazar and Dr Suresh Mallikaarjun

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004269870

  16. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

    Human Psychopharmacology: Clinical and Experimental

    Volume 24, Issue 2, March 2009, Pages: 145–152, Frank C Schieber, David W Boulton, Alfred H Balch, Robert Croop, Suresh Mallikaarjun, Jeannine Benson and Berit X Carlson

    Version of Record online : 8 JAN 2009, DOI: 10.1002/hup.999

  17. Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy

    International Journal of Clinical Practice

    Volume 68, Issue 11, November 2014, Pages: 1301–1308, D. E. Casey, K. K. Laubmeier, J. M. Eudicone, R. Marcus, R. M. Berman, Z. Rahman and J. Sheehan

    Version of Record online : 6 SEP 2014, DOI: 10.1111/ijcp.12480

  18. You have free access to this content
    Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: A subgroup analysis and Montgomery–Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study

    Psychiatry and Clinical Neurosciences

    Volume 69, Issue 1, January 2015, Pages: 34–42, Norio Ozaki, Tempei Otsubo, Masaki Kato, Teruhiko Higuchi, Hiroaki Ono, Kunitoshi Kamijima and ADMIRE Study Group

    Version of Record online : 4 AUG 2014, DOI: 10.1111/pcn.12214

  19. Global benefit–risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 10, October 2009, Pages: 965–972, Stephen R. Wisniewski, PhD, Chi-Chang Chen, PhD, Edward Kim, MD, MBA, Hong J. Kan, PhD, Zhenchao Guo, PhD, Berit X. Carlson, PhD, Quynh-Van Tran, Pharm D, BCPP and Andrei Pikalov, MD, PhD

    Version of Record online : 6 AUG 2009, DOI: 10.1002/pds.1805

  20. Silent saliva aspiration in Parkinson's disease

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 138–141, Bernardo Rodrigues, Ana Caline Nóbrega, Marília Sampaio, Natalie Argolo and Ailton Melo

    Version of Record online : 16 NOV 2010, DOI: 10.1002/mds.23301